These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 12898083)
1. The role of pharmacotherapy in assisting smoking cessation. Waring WS Eur J Clin Pharmacol; 2003 Sep; 59(5-6):351-6. PubMed ID: 12898083 [TBL] [Abstract][Full Text] [Related]
2. [Methods and cost effectiveness of nicotine abstinence]. Górecka D Pol Merkur Lekarski; 2004 May; 16 Suppl 1():79-82. PubMed ID: 15524024 [TBL] [Abstract][Full Text] [Related]
3. Buproprion, public funding, and smoking cessation. Bloomfield A N Z Med J; 2005 Jul; 118(1218):U1576. PubMed ID: 16027759 [No Abstract] [Full Text] [Related]
4. Current pharmacological treatments for nicotine dependence. George TP; O'Malley SS Trends Pharmacol Sci; 2004 Jan; 25(1):42-8. PubMed ID: 14723978 [TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of tobacco dependence. Talwar A; Jain M; Vijayan VK Med Clin North Am; 2004 Nov; 88(6):1517-34. PubMed ID: 15464111 [TBL] [Abstract][Full Text] [Related]
6. The place of pharmacotherapy products in smoking cessation. Percival J Prof Nurse; 2003 Oct; 19(2):113-7. PubMed ID: 14593787 [TBL] [Abstract][Full Text] [Related]
7. Bupropion for smoking cessation: a review. Tong EK; Carmody TP; Simon JA Compr Ther; 2006; 32(1):26-33. PubMed ID: 16785579 [TBL] [Abstract][Full Text] [Related]
8. PHARMAC and tobacco control in New Zealand: government policy 'up in smoke'. Holt S; Harwood M; Aldington S; Beasley R N Z Med J; 2005 Jun; 118(1216):U1502. PubMed ID: 15937536 [TBL] [Abstract][Full Text] [Related]
9. [Bupropion. An antidepressant used to help smoking cessation]. Taeron C Rev Infirm; 2002 May; (81):47-9. PubMed ID: 12078615 [No Abstract] [Full Text] [Related]
10. Achieving tobacco cessation: current status, current problems, future possibilities. Vaszar LT; Sarinas PS; Lillington GA Respiration; 2002; 69(5):381-4. PubMed ID: 12232442 [TBL] [Abstract][Full Text] [Related]
11. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753 [TBL] [Abstract][Full Text] [Related]
12. Review of bupropion for smoking cessation. Richmond R; Zwar N Drug Alcohol Rev; 2003 Jun; 22(2):203-20. PubMed ID: 12850907 [TBL] [Abstract][Full Text] [Related]
14. Helping smokers quit through pharmacogenetics. Lerman C LDI Issue Brief; 2006; 11(6):1-4. PubMed ID: 16827222 [TBL] [Abstract][Full Text] [Related]
15. Smoking cessation: the role of bupropion among new pharmacologic agents. Nardini S Monaldi Arch Chest Dis; 2001 Oct; 56(5):467-72. PubMed ID: 11887507 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of nicotine addiction. Drug therapy for smoking cessation]. Pedersen ST; Christensen HR; Døssing M Ugeskr Laeger; 2002 Mar; 164(11):1480-4. PubMed ID: 11924470 [TBL] [Abstract][Full Text] [Related]
17. A cost-effectiveness evaluation of single and combined smoking cessation interventions in Texas. Hill A Tex Med; 2006 Aug; 102(8):50-5. PubMed ID: 17115560 [No Abstract] [Full Text] [Related]
18. Tobacco addiction and pharmacological interventions. Garrett BE; Rose CA; Henningfield JE Expert Opin Pharmacother; 2001 Oct; 2(10):1545-55. PubMed ID: 11825298 [TBL] [Abstract][Full Text] [Related]